Literature DB >> 13761708

Active polypeptides derived from plasma proteins.

G P LEWIS.   

Abstract

Keywords:  BLOOD PROTEINS/chemistry; PEPTIDES/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13761708     DOI: 10.1152/physrev.1960.40.4.647

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


× No keyword cloud information.
  32 in total

1.  POTENTIATION OF THE ACTION OF BRADYKININ ON SMOOTH MUSCLE BY CHYMOTRYPSIN, CHYMOTRYPSINOGEN AND TRYPSIN.

Authors:  H EDERY
Journal:  Br J Pharmacol Chemother       Date:  1964-04

2.  A COMPARISON OF THE EFFECTS OF THE PLASMA KININS, BRADYKININ AND KALLIDIN, ON MYOCARDIAL BLOOD FLOW AND METABOLISM.

Authors:  J R PARRATT
Journal:  Br J Pharmacol Chemother       Date:  1964-02

3.  KININ FORMATION BY PLASMIN, AN INDIRECT PROCESS MEDIATED BY ACTIVATION OF KALLIKREIN.

Authors:  W VOGT
Journal:  J Physiol       Date:  1964-01       Impact factor: 5.182

4.  [THE EFFECTS OF BRADYKININ AND KALLIDIN ON KIDNEY FUNCTION IN DOGS].

Authors:  O HEIDENREICH; P KELLER; Y KOOK
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-05-29

5.  KININ-FORMING AND DESTROYING ACTIVITIES OF SALIVA.

Authors:  E AMUNDSEN; K NUSTAD
Journal:  Br J Pharmacol Chemother       Date:  1964-12

6.  A STABLE SUBSTRATE FOR THE ASSAY OF PLASMA KININ-FORMING ENZYMES.

Authors:  E AMUNDSEN; K NUSTAD; B WAALER
Journal:  Br J Pharmacol Chemother       Date:  1963-12

7.  The inflammatory response.

Authors:  W G SPECTOR; D A WILLOUGHBY
Journal:  Bacteriol Rev       Date:  1963-06

8.  Substance P, a highly active naturally occurring polypeptide.

Authors:  W HAEFELY; A HUERLIMANN
Journal:  Experientia       Date:  1962-07-15

9.  Analgesic-antipyretic drugs as inhibitors of kallikrein.

Authors:  B J NORTHOVER; G SUBRAMANIAN
Journal:  Br J Pharmacol Chemother       Date:  1961-08

10.  Bradykinin as a vasodilator in man.

Authors:  R H FOX; R GOLDSMITH; D J KIDD; G P LEWIS
Journal:  J Physiol       Date:  1961-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.